Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes

NCT00770367 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Pioglitazone then Placebo
DRUG: Placebo then Pioglitazone

Sponsor

Medical University of South Carolina

Collaborators

[object Object]